دورية أكاديمية

‘Occult’ mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

التفاصيل البيبلوغرافية
العنوان: ‘Occult’ mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
المؤلفون: Sotlr, K., Saeger, W., Stellmacher, F., Stahmer, J., Jäckle, S., Valent, P., Horny, H.-P.
المصدر: Journal of Clinical Pathology. Aug2006, Vol. 59 Issue 8, p875-878. 4p. 1 Diagram.
مصطلحات موضوعية: *MAST cell disease, *CONNECTIVE tissue diseases, *IMMUNOLOGIC diseases, *MULTIPLE myeloma, *B cell lymphoma, *AMYLOIDOSIS, *LYMPHOPROLIFERATIVE disorders
مستخلص: A case of a 70-year-old man presenting with exsudative enteropathy due to light-chain-associated amyloidosis is reported. The diagnosis of systemic mastocytosis associated with IgG/λ plasma cell myeloma and secondary generalised amyloidosis was carried out by morphological evaluation of bone marrow biopsy. The c-kit point mutation D816Y was detected by molecular analysis. Two years before, a cystadenolymphoma of the left parotid gland had been removed. A moderate increase of loosely scattered spindle- shaped mast cells, a subpopulation of them expressing CD25, an antigen that is not expressed by normal or reactive mast cells, was shown by retrospective analysis carried out on art intraparotideal lymph node. The c-kit mutation D816Y was shown by the molecular analysis of the lymph node. In summary, the notion that systemic mastocytosis may very rarely be associated with B cell neoplasms and that neoplastic mast cell infiltrates may be obscured because of only a minimal increase of atypical mast cells, which are outnumbered by other non-neoplastic cells in the same tissue, is supported by this case. This finding was preliminarily termed ‘occult’ mastocytosis. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:00219746
DOI:10.1136/jcp.2005.028837